Mr. Crow is a retired pharmaceutical and life science executive with experience in general management, product development, business development, sales, and marketing. Mr. Crow co-founded and served as President and CEO of Hystagel and Aquintel. Previously, Mr. Crow held the positions of director of international operations at Alza Corporation and area director for an eight-country Asian region, and director of business and public sector development for Syntex Corporation. Mr. Crow received a BA from San Francisco State University and holds a certificate in finance and accounting from the Wharton School of Business.
Current role